Epidemiological and clinical profile of toxidermia at the Departmental University Hospital Center of Borgou/Alibori, Benin.

Bibliographic Details
Title: Epidemiological and clinical profile of toxidermia at the Departmental University Hospital Center of Borgou/Alibori, Benin.
Authors: Akpadjan, Fabrice1,2 barfice@yahoo.fr, Agbessi, Nadège2, Dotsop, Laura1,3, Koudoukpo, Christiane3
Source: Our Dermatology Online / Nasza Dermatologia Online. Apr2025, Vol. 16 Issue 2, p136-140. 5p.
Subject Terms: *DRUG eruptions, *STEVENS-Johnson Syndrome, *DRUG side effects, *DERMATOLOGY, *SYMPTOMS, *EPIDEMIOLOGY
Geographic Terms: BENIN
Abstract: Background: Toxidermias are adverse skin reactions caused by medications administered systemically. They cover a wide range of clinical presentations corresponding to different pathophysiological mechanisms. The aim was to study the epidemiological and clinical profile of these drug eruptions at a university hospital in northern Benin. Patients and Methods: This was a cross-sectional, descriptive study based on the medical records of patients seen in dermatology consultations for drug eruptions from January 2009 to June 2022 at the Departmental University Hospital Center of Borgou/Alibori (DUHC-B/A). Epidemiological and clinical data was recorded and analyzed using EpiData 3.1 and IBM SPSS Statistics 21. Results: Out of 8,829 patients, 123 cases of drug eruptions were recorded, resulting in a hospital frequency of 1.39%. The average age of the patients was 33.9 ± 20.7 years, with a range of 1 to 90 years. The male-to-female ratio was 0.98. The most implicated drugs were cotrimoxazole (13.0%), followed by paracetamol (12.2%), amoxicillin (4.9%), and artemether-lumefantrine (4.9%). The time between drug intake and symptom onset ranged from 1 to 7 days in 13.0% of the patients. Fixed drug eruption (FDE) was the most frequent benign drug eruption (52.0%), while Stevens--Johnson syndrome (SJS) was the most frequent severe drug eruption (17.1%). Conclusion: The hospital frequency of drug eruptions was relatively low at the Dermatology and Venereology Unit of DUHC-B/A. Sulfonamides, analgesics, and antimalarials were the most implicated drug categories. The majority of drug eruptions were benign, with FDE being the most common, while SJS was the most frequent severe form. [ABSTRACT FROM AUTHOR]
Copyright of Our Dermatology Online / Nasza Dermatologia Online is the property of Our Dermatology Online and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Academic Search Complete
More Details
ISSN:20819390
DOI:10.7241/ourd.20252.3
Published in:Our Dermatology Online / Nasza Dermatologia Online
Language:English